The emerging treatment of the medication represents a exciting advance in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects multiple pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide234798.bloggactif.com/43511814/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment